1.
Aperna F, Alsugair AK, Fathima S, Tefferi A, Gangat N. Incidental changes in hemoglobin levels in patients with myelofibrosis receiving treatment with sodium-glucose co-transporter-2 inhibitors. Haematologica; https://doi.org/10.3324/haematol.2024.286867 [Early view].